CM Life Sciences Inc. (CMLFU)
NASDAQ: CMLFU
· Real-Time Price · USD
13.00
-0.62 (-4.55%)
At close: Nov 16, 2020, 6:00 AM
CM Life Sciences Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 |
|---|---|---|---|---|
| Diagnostic Test Revenue | 99.82M | 85.76M | 224.74M | 77.42M |
| Diagnostic Test Revenue Growth | +16.40% | -61.84% | +190.29% | n/a |
| Diagnostic Test, Institutional Customers Revenue | 18.38M | 17.6M | 47.7M | 17.41M |
| Diagnostic Test, Institutional Customers Revenue Growth | +4.41% | -63.09% | +173.90% | n/a |
| Diagnostic Test, Self Pay Revenue | 339K | 96K | 1.88M | 460K |
| Diagnostic Test, Self Pay Revenue Growth | +253.12% | -94.90% | +309.35% | n/a |
| Diagnostic Test, Third Party Insurance Revenue | 81.1M | 68.06M | 175.16M | 59.54M |
| Diagnostic Test, Third Party Insurance Revenue Growth | +19.17% | -61.14% | +194.17% | n/a |
| Product and Service, Other Revenue | 2.87M | 1.36M | 3.84M | -544K |
| Product and Service, Other Revenue Growth | +111.58% | -64.66% | -805.33% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 46.86M | 50.45M | 45.03M | 43.17M | 41.76M | 52.52M | 1.28M | 206.19K |
| Selling, General, and Administrative Revenue Growth | -7.11% | +12.05% | +4.30% | +3.39% | -20.50% | +4009.78% | +519.80% | n/a |
| Research and Development Revenue | 15.08M | 12.58M | 11.59M | 11.66M | 10.9M | 17.14M | n/a | n/a |
| Research and Development Revenue Growth | +19.89% | +8.53% | -0.66% | +7.00% | -36.39% | n/a | n/a | n/a |
| Sales and Marketing Revenue | 19.45M | 18.32M | 17.68M | 17.02M | 16.59M | 15.18M | n/a | n/a |
| Sales and Marketing Revenue Growth | +6.18% | +3.62% | +3.82% | +2.65% | +9.24% | n/a | n/a | n/a |